Avandia, the controversial diabetes drug introduced by GlaxoSmithKline in 1999, will no longer be available in retail pharmacies after this November. The FDA announced in September that it would take this action after a study showed Avandia was associated with increased cardiovascular risks. New rules governing the distribution and prescription of Avandia are now being…
Read moreIn the wake of widespread reports of heart failures, liver damage, and other patient injuries and seemingly non-stop controversy surrounding the top-selling type-2 diabetes drug Avandia, the Food and Drug Administration now says that future diabetes drugs will face much tougher scrutiny.
Read moreAvandia, the blockbuster type 2 diabetes drug taken by an estimated six million Americans, has been linked to an increased risk of heart attack and cardiovascular death. Avandia was approved in 1999 for the treatment of type 2, or adult onset, diabetes, which affects an estimated 18 to 20 million Americans and is a leading…
Read moreElderly patients who took the controversial anti-diabetes drug Avandia were more likely to suffer deadly congestive heart failure than patients who took a similar drug, a new study has found. Researchers at Harvard Medical School tracked 28,361 diabetes patients for five years. Roughly half of the patients were treated with Avandia (generic rosiglitazone) while half…
Read more